Section Arrow
VALN.NASDAQ
- Valneva SE
Quotes are at least 15-min delayed:2024/10/31 18:40 EDT
Last
 5.68
-0.17 (-2.91%)
Day High 
5.8 
Prev. Close
5.85 
1-M High
6.2099 
Volume 
18.99K 
Bid
5.65
Ask
5.71
Day Low
5.65 
Open
5.76 
1-M Low
5.4 
Market Cap 
474.30M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.89 
20-SMA 5.8 
50-SMA 6.37 
52-W High 14.49 
52-W Low 5.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.48/-1.02
Enterprise Value
636.15M
Balance Sheet
Book Value Per Share
2.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
153.71M
Operating Revenue Per Share
4.58
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:40 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generatefuture cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue fromproduct sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.